Abiopharma

New Form N-CSRS/A - NUVEEN ARIZONA QUALITY MUNICIPAL INCOME FUND <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001193125-26-353378 <b>Size:</b> 8 MB

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001918704-26-023839 <b>Size:</b> 255 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001140361-26-033314 <b>Size:</b> 109 KB

Gilat Signs $14 Million Agreement to Expand Broadband Internet Access in Peru

Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer

(10% Negative) ZURA BIO LTD (ZURA) Announces Delay in identified Development Timeline Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update

(90% Positive) ENOVIX CORP (ENVX) Reports Q3 2026 Financial Results

Signs $14 Million Agreement to Expand Broadband Internet Access in Peru

Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer. The New Mechanistic Findings Support Can-Fite’s Ongoing Phase IIb Study Design Following Positive Phase IIa Results

Auddia Announces Exclusive Label Partnership with AMG Corp, Making Discovr Radio Its Exclusive Digital Radio Release Channel

Freightos Reports Second Quarter 2026 Results

Castle Biosciences Approved for Dual Listing on Nasdaq Texas

Barings Global Short Duration High Yield Fund Announces August 2026 Monthly Distribution of $0.1223 per Share

Dynatrace Announces Proposed Private Placement of $1.25 Billion of Exchangeable Senior Notes